A Visionary Leader in Healthcare Innovation and Healthcare Policy

Dr. Francis Collins is one of the most influential scientists and healthcare policy leaders of our time, recognized for his groundbreaking contributions to genomics, precision medicine, and national healthcare initiatives. As the Director of the National Institutes of Health (NIH) from 2009 to 2021, he played a pivotal role in shaping the nation’s biomedical research agenda under three U.S. Presidents—Barack Obama, Donald Trump, and Joe Biden. His leadership was instrumental in advancing critical research on diabetes, Alzheimer’s disease, cancer, neuroscience, genetic diseases, and the COVID-19 pandemic.

Revolutionizing Medicine: The Human Genome Project and Beyond

Before his tenure as Director of NIH, Dr. Collins led one of the most significant scientific efforts in modern history—the Human Genome Project. Completed in 2003, this international collaboration successfully mapped the entire human genetic code, revolutionizing genetic medicine, diagnostics, and targeted therapies. His leadership in genomics has had a lasting impact on precision medicine, transforming the way diseases are prevented, diagnosed, and treated.

Physician and geneticist Dr. Francis Collins' life story is one of curiosity, discovery, and deep human connection. His journey from a small-town upbringing to leading the Human Genome Project and serving as Director of the National Institutes of Health is a testament to the power of vision, intellectual courage, and ethical leadership.

Guiding National Healthcare Policy and Research

As NIH Director, Collins secured bipartisan support for major healthcare initiatives, fostering public-private partnerships to accelerate biomedical innovation. Under his leadership:

The Cancer Moonshot Initiative was launched to advance cancer research and treatment.
The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative pushed the frontiers of neuroscience.
The All of Us Research Program paved the way for precision medicine by collecting diverse genetic and health data on close to a million Americans, to drive personalized treatment strategies.
NIH-led COVID-19 vaccine and treatment research played a crucial role in the rapid development of mRNA vaccines and therapeutics.
Global health research was a major priority for NIH, including launching the H3Africa Project and assisting in the design of an African Centers of Excellence Program.
The Sound Health Program, co-led with Renée Fleming, brought together music therapists, neuroscientists, and performers to identify new ways for music to be used for healing.

A Lifelong Commitment to Science and Innovation

Following his tenure as Acting Science Advisor and Special Projects Advisor to President Biden (2022-2023), Collins returned to his NIH research laboratory to continue investigating genetic factors in diabetes and premature aging. He retired from NIH on March 1, 2025, but continues to be a leading voice advocating for the importance of support of biomedical research.

SCIENCE TOPICS

Science